Reckitt Benckiser in talks to acquire Mead Johnson for US$16.7b
New York
RECKITT Benckiser Group Plc is in talks to buy baby formula maker Mead Johnson Nutrition Co for about US$16.7 billion, the latest push by the Durex condom maker to build on its faster growing consumer-health business and bolster its presence in Asian markets.
The companies are discussing an offer of US$90 a share in cash, Reckitt Benckiser said late on Wednesday. That's 29 per cent higher than Mead Johnson's closing stock price. Reckitt Benckiser, based in Slough, England, would finance its biggest-ever deal with cash and debt. Mead Johnson confirmed the discussions in a separate statement, and both companies said there is no certainty that any transaction will ultimately be agreed on.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Carnival’s Princess brand revises 2025 world cruise routes amid Red Sea tensions
Google to pay up to US$6 million to News Corp for new AI content, The Information reports
Restaurant Brands tops estimates as Burger King overhaul pays off
Yen falls after suspected intervention on Monday; eyes on Fed
US: Wall St opens lower on labour costs data
TikTok shop tops 500,000 US sellers after 2023 e-commerce launch